Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Biomerica Inc’s stock clocked out at $0.75, down -10.46% from its previous closing price of $0.84. In other words, the price has decreased by -$10.46 from its previous closing price. On the day, 1.02 million shares were traded.
Ratios:
To gain a deeper understanding of BMRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 3.17. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Colliers Securities on November 10, 2020, initiated with a Buy rating and assigned the stock a target price of $13.
On January 04, 2018, B. Riley FBR Inc. started tracking the stock assigning a Buy rating and target price of $7.50.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.47 while its Price-to-Book (P/B) ratio in mrq is 2.69.
Stock Price History:
Over the past 52 weeks, BMRA has reached a high of $1.35, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 50.13%, while the 200-Day Moving Average is calculated to be 75.52%.
Shares Statistics:
A total of 18.34M shares are outstanding, with a floating share count of 16.35M. Insiders hold about 10.82% of the company’s shares, while institutions hold 7.67% stake in the company.
